RCMI Coordinating Center (RCMI CC) Header Logo

Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature.

Calhoun CC, Cardenes O, Ducksworth J, Le AD. Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature. J Oral Maxillofac Surg. 2009 Nov; 67(11):2516-20.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support